ABT-639 is a novel, peripherally acting, selective T-type Ca2+ channel blocker. ABT-639 blocks recombinant human T-type (Cav3.2) Ca2+ channels in a voltage-dependent fashion (IC50 = 2 M) and attenuates LVA currents in rat DRG neurons (IC50 = 8 M).
ABT-639 is significantly less active at other Ca2+ channels (e.g. Cav1.2 and Cav2.2) (IC50 > 30 M). ABT-639 has high oral bioavailability (%F = 73), low protein binding (88.9%) and a low brain:plasma ratio (0.05:1) in rodents.
仅供研究使用。 我们不向患者出售。
名称 | ABT-639 |
---|---|
Iupac 化学名称 | ABT-639 |
同义词 | ABT639; ABT 639 |
英文同义词 | ABT639; ABT 639 |
分子式 | C20H20ClF2N3O3S |
分子量 | 455.91 |
InChiKey | |
InChi | |
Cas号 | 1235560-28-7 |
相关CAS号 |
包装 | 价格 | 库存 | 纯度 | 备货期 |
---|---|---|---|---|
大货 | 询价 | 询价 | 询价 |